C07D 217/12
Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems: with radicals, substituted
Official title: with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
C07D217/12 (Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems: with radicals, substituted) appears on 758 US grants and 676 published applications in this corpus.
Search patents in C07D- Granted patents
- 758
- Published applications
- 676
- Assignees
- 431
- Inventors
- 2,620
- Latest grant
- 22 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 12 | 0 |
| 1977 | 18 | 0 |
| 1978 | 14 | 0 |
| 1979 | 9 | 0 |
| 1980 | 11 | 0 |
| 1981 | 9 | 0 |
| 1982 | 9 | 0 |
| 1983 | 9 | 0 |
| 1984 | 7 | 0 |
| 1985 | 12 | 0 |
| 1986 | 11 | 0 |
| 1987 | 10 | 0 |
| 1988 | 15 | 0 |
| 1989 | 10 | 0 |
| 1990 | 8 | 0 |
| 1991 | 4 | 0 |
| 1992 | 9 | 0 |
| 1993 | 15 | 0 |
| 1994 | 8 | 0 |
| 1995 | 12 | 0 |
| 1996 | 13 | 0 |
| 1997 | 23 | 0 |
| 1998 | 14 | 0 |
| 1999 | 14 | 0 |
| 2000 | 14 | 0 |
| 2001 | 6 | 2 |
| 2002 | 10 | 15 |
| 2003 | 13 | 26 |
| 2004 | 16 | 38 |
| 2005 | 13 | 31 |
| 2006 | 12 | 27 |
| 2007 | 17 | 28 |
| 2008 | 9 | 26 |
| 2009 | 17 | 35 |
| 2010 | 23 | 44 |
| 2011 | 24 | 22 |
| 2012 | 32 | 22 |
| 2013 | 29 | 25 |
| 2014 | 25 | 43 |
| 2015 | 42 | 42 |
| 2016 | 23 | 30 |
| 2017 | 29 | 22 |
| 2018 | 14 | 21 |
| 2019 | 23 | 29 |
| 2020 | 17 | 21 |
| 2021 | 19 | 27 |
| 2022 | 13 | 19 |
| 2023 | 8 | 27 |
| 2024 | 13 | 19 |
| 2025 | 14 | 23 |
| 2026 | 7 | 12 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- N-heteroarylalkyl-2-(heterocyclyl and heterocyclylmethyl) acetamide derivatives as SSTR4 agonists22 Sep 2026US 12,741,957 B2Takeda Pharmaceutical Company Limited
- Compound for treating Alzheimer's disease16 Jun 2026US 12,655,088 B2East China University of Science and Technology
- Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof26 May 2026US 12,637,400 B2Duk San Neolux Co., Ltd.
- Hydrazone derivative in which terminal amine group is substituted with aryl group or heteroaryl group, and use thereof31 Mar 2026US 12,590,071 B2Korea Institute of Science and Technology
- Compositions and methods for treatment24 Feb 2026US 12,558,350 B2Bausch + Lomb Ireland Limited
- Aryl hydrocarbon receptor agonist prodrugs and methods of use thereof10 Sep 2026US 2026/0263431 A1Allianthera Boston Inc.
- Methods of producing morphinan alkaloids and derivatives27 Aug 2026US 2026/0250729 A1Antheia, Inc.
- Preparation method and application of a chiral amine compound and its salts6 Aug 2026US 2026/0226520 A1Tongli Biomedical Co., Ltd.
- Masp-2 inhibitors and methods of use9 Jul 2026US 2026/0193179 A9Omeros Corporation
- Methods for treating cancer14 May 2026US 2026/0130925 A1Genesis Molecular AI, Inc.
Most cited
By later US patents
- Retroviral protease inhibiting compounds159US 5,142,056 AAbbott Laboratories · 1992
- Anti-estrogenic compounds and compositions119US 5,395,842 AEndorecherche, Inc. · 1995
- Retroviral protease inhibiting compounds109US 5,354,866 AAbbott Laboratories · 1994
- 5-substitued-6-cyclic-5,6,7,8-tetrahydronaphthalen2-ol compounds which are useful for treating osteoporosis98US 5,552,412 APfizer Inc. · 1996
- Sulfonamides and their use as a medicament87US 8,088,772 B2The Genetics Company, Inc. · 2012